ABSTRACT

Epilepsy is one of the most common and disabling neurological disorders of the brain influencing approximately 50 million people around the world disorder affecting all groups of ages. There are nearly 125,000 new cases of epilepsy each year and about 30% of patients are less than 18 years old. Several epilepsy diagnosis and treatment advances have recently been introduced providing pharmacists with tremendous opportunities to help improve drug therapy for epilepsy and various advanced drugs each with specific health, effectiveness and cost requirements, are available for treating seizures. The aim is to reduce the frequency and severity of seizures while reducing damage to the brain and other tissues by treating epilepsy with drugs. A variety of biological factors, particularly the blood-brain barrier, have severely limited drug access to the brain and contributed to the use of drugs loaded into the nanoparticles. This review attempts to describe the classification of seizures, epidemiology and available diagnostic procedures and the antiepileptic drugs used to treat epilepsy. Keywords: Epilepsy; Seizures; Treatment; Anti-Epileptic Drugs; Mechanisms; Nano drug delivery
Publication date: 01/12/2020

https://ijbpas.com/pdf/2020/December/MS_IJBPAS_2020_5289.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2020/9.12.5289